Last reviewed · How we verify

NCT03830541: CREASED

Oral Health Care in Autism Spectrum Disorder

Status unknown Last updated 13 March 2019
What this trial tests

trial testing Oral care delivery analysis in participants with ASD in Autism Spectrum Disorder in 52 participants. Status unknown.

Timeline
20 March 2019
Primary endpoint
20 July 2019
20 December 2019

Quick facts

Lead sponsorUniversity of Novi Sad
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment52
Start date20 March 2019
Primary completion20 July 2019
Estimated completion20 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

University of Novi Sad

Who can join

Adults 3 to 80, any sex, with Autism Spectrum Disorder or Autism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Persons with autism spectrum disorder (ASD) are characterized by impairments in social interactions, speech and communication, restricted patterns of behaviour, and unusual sensory sensitivities. There are not many studies available reporting oral health status, dental care needs and oral health care protocol for persons with an ASD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other University of Novi Sad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03830541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing